Answers before you evaluate

Your product roster (ingredients, claims, categories, and related attributes) is normalized into structured profiles. Those profiles are assessed against the live signal set so each product–signal pair can show exposure, recommended action type, owner, urgency, and a short review narrative—making concentration and accountability visible.

If you have a roster, typical intake is spreadsheet or PDF-based product data. The goal is a validated canonical record per SKU (or equivalent) so assessment runs on explicit fields—not hidden assumptions in one-off spreadsheets. You do not need to upload a portfolio to research an ingredient or draft Ingredient diligence.

RegSig is built around structured signals with provenance and scores, joined to products in a repeatable way. The output is review-oriented rows and triage views, not an unprioritized document pile.

A signal is a consolidated regulatory change record: title, summary, topic, origin metadata (source type, authority, jurisdiction), horizon, impact and confidence scores, recommended action language, evidence across related actions, and a derived Act / Prepare / Monitor posture for triage.

The same signal objects power executive-oriented summaries and line-level portfolio assessment. When a product is exposed, reviewers can trace why: the signal row carries the context that backs the mapping.

RegSig emphasizes how regulatory intent progresses across origins over time—so teams can interpret early signals alongside rulemaking, guidance, and enforcement-grade triggers without treating every update as equally urgent.

Yes. Research and Ingredient diligence work from a searched substance. No roster is required. Upload a portfolio when you need product-level exposure, owners, and assessment rows.

Ingredient diligence is a register-linked brief for a nominated substance (compliance, labelling, residual risk) for human review—it is not legal advice and not a client send until an operator approves it. M&A diligence is a separate deal-level risk lens on a portfolio, typically for institutional programs. They are not the same module.

Organizations that need repeatable triage across a real product portfolio: regulatory affairs, product compliance, portfolio or program leads, and leaders who want concentration visibility without losing traceability to evidence.

Look for structured signals with provenance, portfolio assessment outputs with ownership fields, and review surfaces that match how your team works (dashboard scan, signal validation, portfolio execution). User access is reviewed for fit and governance needs.

No. RegSig is not legal advice and not a substitute for counsel. It is an intelligence layer for regulatory change and portfolio impact. Many teams use it alongside existing workflow and GRC investments.

RegSig Inc. is a Delaware C-Corp and a wholly-owned subsidiary of On the M.A.R.C. Holdings LLC. Proprietary methods may be legally protected (patent pending).

Email support@regsig.com for product support and inquiries. For deployment conversations, use Request user access on the main site.